unknown
Stage
1
Investors
About
BioCryst Pharmaceuticals is a global biotechnology company focused on discovering, developing, and commercializing oral small-molecule and injectable protein therapeutics for rare diseases, including hereditary angioedema (HAE).
Explore BioCryst Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.